as 02-21-2025 4:00pm EST
GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.
Founded: | 2001 | Country: | United States |
Employees: | N/A | City: | RUTHERFORD |
Market Cap: | 5.1M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 4.1M |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -57.77 | EPS Growth: | N/A |
52 Week Low/High: | $0.36 - $99.00 | Next Earning Date: | 03-27-2025 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
GCTK Breaking Stock News: Dive into GCTK Ticker-Specific Updates for Smart Investing
GuruFocus.com
17 days ago
Medical Device Network
18 days ago
MT Newswires
18 days ago
GlobeNewswire
18 days ago
GlobeNewswire
19 days ago
GlobeNewswire
24 days ago
MT Newswires
24 days ago
GlobeNewswire
25 days ago
The information presented on this page, "GCTK GlucoTrack Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.